Document is current
Any future updates will be listed below
-
Authors
Sarti, Alberto
Verardi, Filippo Maria
Cavazza, Caterina
Erriquez, Andrea
Casella, Gianni
Guiducci, Vincenzo
Moreno, Raul
Escaned, Javier
Marchini, Federico
Cocco, Marta
Caglioni, Serena
Farina, Jacopo
Vadalà, Giuseppe
Capecchi, Alessandro
Gallo, Francesco
Cerrato, Enrico
Menozzi, Alberto
Gil, Jose Luiz Diez
Santos, Ignacio Amat
Ruozzi, Marco
Barbierato, Marco
Picchi, Andrea
Pavasini, Rita
Scarsini, Roberto
Tebaldi, Matteo
Campo, Gianluca
Biscaglia, Simone
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03772743 at ClinicalTrials.govDocuments that mention this clinical trial
Diabetes does not attenuate the benefit of physiology-guided complete revascularization in older patients with myocardial infarction
https://doi.org/10.1186/s12933-026-03165-5
Health-Status Outcomes in Older Patients With Myocardial Infarction: Physiology-Guided Complete Revascularization Versus Culprit-Only Strategy
https://doi.org/10.1161/circoutcomes.123.010490
Complete Revascularization in Older Patients With Myocardial Infarction With or Without Complex Nonculprit Lesions
https://doi.org/10.1161/circinterventions.125.015902
- License Information
-
More Information
Article History
Received: 21 February 2026
Accepted: 21 March 2026
First Online: 14 April 2026
Declarations
:
: All enrolled patients provided written informed consent, and the trial protocol was approved by the institutional review board at each participating center. The trial was registered on ClinicalTrials.gov with the identifier NCT03772743.
: None.
: The authors declare no competing interests.
